BG Medicine (BGMD) IPO Gets Priced, But at a Cost
Tweet Send to a FriendGet Alerts BGMD Hot Sheet
Trade BGMD Now!
BG Medicine (NASDAQ: BGMD) priced its 5,000,000 share initial public offering at $7, in-line with the expected price, which was cut recently from a range of $13-$15. Shares will open today on the NASDAQ under the symbol "BGMD."
The sole bookrunning manager is Lazard Capital Markets LLC.
BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The sole bookrunning manager is Lazard Capital Markets LLC.
BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Elon Musk Says SpaceX Won't IPO Until Mars is a Reality
- Coty (COTY) IPO Opens Flat
- Loeb Boosts Sony (SNE) Stake, Continues Urging IPO on Entertainment Unit
Create E-mail Alert Related Categories
IPOsRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
